Shashank Radadiya, MD
Rheumatology · Kansas City, KSNPI 1306887161
Payments from drug & device makers
Across 710 payments — averaging $103.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$67K
- Amgen$4K
- Lilly USA, LLC$413
- Novartis$375
- Johnson & Johnson$324
- Pfizer$319
- plus $2K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 279 | $67,161 |
| Amgen(2 entities) | 233 | $3,520 |
| Lilly USA, LLC | 32 | $413 |
| Novartis | 18 | $375 |
| Johnson & Johnson(2 entities) | 12 | $324 |
| Pfizer | 50 | $319 |
| E.r. Squibb & Sons, L.L.C. | 21 | $253 |
| AstraZeneca(2 entities) | 7 | $196 |
| Bayer | 5 | $182 |
| Boehringer Ingelheim | 8 | $178 |
| UCB, Inc. | 8 | $148 |
| Novo Nordisk | 5 | $108 |
| GSK | 6 | $107 |
| Mallinckrodt Hospital Products Inc. | 2 | $87 |
| Fresenius Kabi USA, LLC | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 4 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Organon | 2 | $36 |
| Sanofi | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
| Dexcom, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Valeritas, Inc. | 1 | $17 |
| Abbott | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$73,761 in reported general payments places this provider in the 90th percentile of 49 rheumatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Kansas City
- Paul SchmidtKansas City$143K
- Herbert LindsleyKansas City$13K
- Kavish SinghKansas City$2K
- Kasey McDonaldKansas City$740
- Rashmi ThimmapuramKansas City$471
- Michael DennisKansas City$452
- Sarah Abi DoumethKansas City$103
- Amy MarkeyKansas City$84
- Amrita BathKansas City$28
- Sarah IfteqarKansas City$27
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.